San Francisco 29 April
2019 The Report Sustained Release Excipients Market Size, Share & Trends Analysis Report By
Product (Polymers, Gelatin), By Route of Administration (Oral, Transdermal), By
Technology (Targeted Delivery), And Segment Forecasts, 2018 – 2026
The global sustained release excipients market size is expected to reach USD 1.6 billion by 2026 at a 7.1% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Increasing focus on novel drug delivery R&D and rising adoption of extended release formulations for treatment of chronic diseases are major factors driving the market.
Use of sustained release drug formulations provides
patients relief from these symptoms and helps maintain desired therapeutic drug
levels in the body. In comparison to conventional drugs, sustained drug release
technologies provide a wide range of benefits. Reduced dosage frequency,
improved patient compliance, maintenance of constant level of drug in blood
plasma, lower instances of toxicity due to overdose, and higher
cost-effectiveness in the long run are some of the major advantages of using
this technology.
Global rise in incidence of chronic and
infectious diseases has also resulted in antibiotic resistance, which
negatively affects the market for conventional dosage forms. Thus, alternative
methods to manage and treat these diseases are being implemented. Use of
sustained release formulations has been widely accepted among physicians in
order to combat antibiotic resistance. Since these formulations create desired
therapeutic drug levels in blood plasma and reduce dosage frequency, they are
the preferred choice of formulation among physicians, which increases their
demand.
Access Research Report of Sustained Release Excipients Market
@ https://www.grandviewresearch.com/industry-analysis/sustained-release-excipients-market
Further key findings from the report suggest:
· Polymers formed the largest revenue
grossing segment by product type in 2017 and is anticipated to grow at a
lucrative rate during the forecast period. This is due to its high adoption in
sustained release formulations as they provide greater strength and improved
shelf-life
· In terms of route of administration, the
oral segment held the dominant share in 2017 and is projected to witness steady
growth to retain its lead throughout the forecast period
· Transdermal technology is expected to
exhibit the highest CAGR during the forecast period owing to its escalating
usage. It minimizes various limitations associated with oral and parenteral
route of administrations
· North America dominated the overall market
in 2017 due to well-developed research infrastructure and presence of leading
pharmaceutical and biopharmaceutical companies
· Asia Pacific is spearheading revenue
growth, with Japan, China, and India at the forefront
· Some of the key companies in the market are
Coating Place, Inc.; Depomed, Inc.; Corium International, Inc.; Capsugel;
Aradigm Corporation; Orbis Biosciences, Inc.; and Alkermes plc.
Browse more reports of this category by Grand View
Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has
segmented the global sustained release excipients market on the basis of
product, route of administration, technology, and region:
Sustained Release Excipients Product
Outlook (Revenue, USD Million, 2015 - 2026)
·
Gelatin
·
Polymers
·
Minerals
·
Sugars
·
Alcohol
·
Chitosan
Sustained Release Excipients Route of
Administration Outlook (Revenue, USD Million, 2015 - 2026)
·
Oral
·
Intramuscular
·
Subcutaneous
·
Transdermal
·
Vaginal
·
Ophthalmic
·
Intravenous
·
Others
Sustained Release Excipients Technology
Outlook (Revenue, USD Million, 2015 - 2026)
·
Targeted Delivery
·
Micro Encapsulation
·
Wurster Technique
·
Transdermal
·
Implants
·
Coacervation
·
Others
Sustained Release Excipients Regional
Outlook (Revenue, USD Million, 2015 - 2026)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
Sustained Release Excipients Market@ https://www.grandviewresearch.com/press-release/global-sustained-release-excipients-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment